ctrl K

Watchlist Price Alert

Reviva Pharmaceuticals I... (RVPH)

NASDAQ: RVPH · Real-Time Price · USD

0.35

-0.41 (-54.17%)

At close: Jun 26, 2025, 3:59 PM

Reviva Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Feb 29, 2020	Feb 28, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	724.74K	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	-724.74K	n/a	n/a
Operating Income	-30.8M	-39.5M	-24.31M	-10.1M	-2.43M	-376.86K	-1.12M
Interest Income	361.37K	n/a	182.8K	n/a	105.18K	201.00	n/a
Pretax Income	-29.9M	-39.24M	-24.32M	-8.52M	-3.78M	-846.03K	-1.68M
Net Income	-29.92M	-39.26M	-24.34M	-8.52M	-3.78M	-846.83K	-1.68M
Selling & General & Admin	7.89M	8.08M	5.36M	5.25M	2.14M	181.12K	175.58K
Research & Development	22.91M	31.42M	18.95M	4.85M	295.15K	195.74K	946.3K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-0.00
Operating Expenses	30.8M	39.5M	24.31M	10.1M	2.43M	376.86K	1.12M
Interest Expense	18.5K	n/a	182.8K	2.41K	1.45M	469.37K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-30.8M	39.5M	24.31M	10.1M	2.43M	376.86K	1.12M
Income Tax Expense	19.51K	-16.95K	20.78K	6K	800.00	800.00	800.00
Shares Outstanding (Basic)	33.15M	23.8M	19.52M	14.79M	3.06M	2.77M	2.04M
Shares Outstanding (Diluted)	33.15M	23.8M	19.52M	14.79M	3.06M	2.77M	2.04M
EPS (Basic)	-0.9	-1.65	-1.45	-0.58	-1.24	-0.31	0.28
EPS (Diluted)	-0.9	-1.65	-1.45	-0.58	-1.24	-0.31	0.28
EBITDA	-29.88M	-39.5M	-24.11M	-10.1M	-2.33M	-376.01K	-1.12M
EBIT	-29.88M	-39.24M	n/a	n/a	n/a	n/a	-1.12M
Depreciation & Amortization	n/a	n/a	194.71K	236.56K	105.77K	846.00	1.02K